Design and Development of Fast-dissolving Tablets of Apixaban using Single Coprocessed Excipient



  • Sourabh Jaiswal SVKM NMIMS School of Pharmacy and Technology Management, Shirpur, Dhule
  • Abhishek Kanugo SVKM NMIMS School of Pharmacy and Technology Management, Shirpur, Dhule


Background: Apixaban is administered orally as an anticoagulant action and minimizes the chances of strokes and systemic embolism. The conventional film-coated tablet showed less bioavailability due to its minimal solubility in the gastrointestinal tract. 

Rationale: The goal of designing the current analysis is to prepare a prompt release tablet using a single Coprocessed excipient which minimizes multistep processing, time, and cost effectiveness.

Methods: The prompt release tablets of Apixaban were developed by direct compression technique using multifunctional material like Prosolve ODT G2 and Prosolve Easytab. Drug excipients inertness was confirmed with FTIR and DSC. Flowing characteristics of Apixaban and co-processed excipients were evaluated in terms of Carr’s index, Angle of repose, and Hausner’s ratio. These co-processed excipients indicated exceptional flowing and compression characteristics. The ready tablets were assessed for weight variation, hardness, friability, dispersion time, disintegration, and dissolution studies.

Results: Among 12 batches, the least disintegration time was shown with C6 with a cumulative drug release of 99.06 % within 25 min. The optimized batch C6 was highly stable when tested under stability guidelines at 40 0 C and at 75 % relative humidity.  

Conclusion: Among these co-processed excipients, Prosolve Easytab SP was found the best one for direct compression intended for the immediate or fast dissolving tablets. 


Download data is not yet available.


Metrics Loading ...


Fast dissolving tablet, Apixaban, co-processed excipients, Prosolve ODT G2, Easytab, direct compression



How to Cite

Jaiswal S, Kanugo A. Design and Development of Fast-dissolving Tablets of Apixaban using Single Coprocessed Excipient. Scopus Indexed [Internet]. 2024 Mar. 31 [cited 2024 Jun. 14];17(2):7217-26. Available from:



Research Articles


Abd El Rasoul S, Shazly GA. Propafenone HCl fast dissolving tablets containing subliming agent prepared by direct compression method. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc [Internet]. 2017 Nov 1 [cited 2023 Aug 5];25(7):1086–92.

Kanugo A, Gandhi Y. Formulation optimization and evaluation of oral thin film of bilastine for the treatment of allergic conditions. J Res Pharm. 2022;26(5):1214–29.

Dave V, Yadav RB, Ahuja R, Yadav S. Formulation design and optimization of novel fast dissolving tablet of chlorpheniramine maleate by using lyophilization techniques. Bull Fac Pharmacy, Cairo Univ. 2017 Jun 1;55(1):31–9.

Kanugo A, Mathur VB. Evaluation and Comparison of Highly Soluble Sodium Stearyl Fumarate with Other Lubricants In Vitro | Semantic Scholar [Internet]. [cited 2022 May 20].

Russell A, Strong J, Garner S, Ketterhagen W, Long M, Capece M. Direct Compaction Drug Product Process Modeling. AAPS PharmSciTech 2022 231 [Internet]. 2022 Jan 31 [cited 2023 Aug 5];23(1):1–28.

Main A, Bhairav BA, Saudager RB. Co processed excipients for tabletting: Review article. Res J Pharm Technol. 2017 Jul 1;10(7):2427–32.

Bhatia V, Dhingra A, Chopra B, Guarve K. Co-processed excipients: Recent advances and future perspective. J Drug Deliv Sci Technol. 2022 May 1;71:103316.

PROSOLV® ODT G2 [Internet]. [cited 2023 Aug 5]. Available from:

Vlad RA, Antonoaea P, Todoran N, Muntean DL, Rédai EM, Silași OA, et al. Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets. Saudi Pharm J. 2021;29(9):1029–42.

Byon W, Garonzik S, Boyd RA, Frost CE. Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review. Clin Pharmacokinet [Internet]. 2019 Oct 1 [cited 2023 Jul 16];58(10):1265–79.

Apixaban: Uses, Interactions, Mechanism of Action | DrugBank Online [Internet]. [cited 2023 Aug 5]. Available from:

Kanugo A. Liquisolid-Pellets Technique: A Recent Technique For Enhancing Solubility And Bioavailability Of Drugs. Int J Appl Pharm [Internet]. 2020 Nov 7 [cited 2022 Feb 26];12(6):34–40.

Sharma S, Kanugo A, Kaur T, Chaudhary D. Formulation and Characterization of Self-Microemulsifying Drug Delivery System (SMEDDS) of Sertraline Hydrochloride. Recent Pat Nanotechnol. 2022 Jun 24;16.

Taghizadeh Z, Rakhshani S, Jahani V, Rajabi O, Haghighi HM, Abbaspour M. Preparation and in vitro characterization of carvacrol pellets by combination of liquisolid technique and extrusion-spheronization. J Drug Deliv Sci Technol. 2021 Feb 1;61:102232.

Kanugo A, Dugad T. Design Optimization and Evaluation of Solid Lipid Nanoparticles of Azelnidipine for the treatment of Hypertension. Recent Pat Nanotechnol [Internet]. 2022 Oct 19 [cited 2022 Nov 6];17.

Kanugo AY, Kochar NI, Chandewar AV, Dhabarde DM, Dhawral VG. Design and evaluation of enteric compression-coated tablet for chronotherapeutic drug delivery. Asian J Pharm. 2017;11(3).

Suthar C, Kanugo A. Liquisolid Compact Technique for the Enhancement of Solubility and Dissolution Rate of Ambrisentan: Quality by Design Approach. Indian J Pharm Sci. 2022;84(6):1417–28.

Sreeharsha N, Naveen NR, Anitha P, Goudanavar PS, Ramkanth S, Fattepur S, et al. Development of Nanocrystal Compressed Minitablets for Chronotherapeutic Drug Delivery. Pharmaceuticals. 2022;15(3).

Godbole M, Thangan A, Kanugo A. Improvement of solubility and dissolution rate of Repaglinide by Liquisolid Compact technique: QbD approach. J Res Pharm. 2022;26(6):1573–92.

Kanugo AY, Kochar NI, Chandewar AV. Development of pulsatile drug delivery for chronotherapeutics of hypertension. Int J Drug Deliv Technol. 2017;7(3).

Kanugo A, Thanvi A. Neusilin US2 based Liquisolid Compact technique for the enhancement of solubility and dissolution rate of Olmesartan: Box-Behnken design approach. J Res Pharm. 2023;27(1)(27(1)):52–66.

Jaipakdee N, Tabboon P, Limpongsa E. Application of a liquisolid technique to cannabis sativa extract compacts: Effect of liquid vehicles on the dissolution enhancement and stability of cannabinoids. Int J Pharm. 2022 Jan 25;612:121277.

Kanugo A, Dhage R. pH-dependent pulsatile delivery of Ambrisentan for the treatment of hypertension. J Res Pharm. 2023;27(2)(27(2)):848–59.

Suram D, Narala A, Veerabrahma K. Development, characterization, comparative pharmacokinetic and pharmacodynamic studies of iloperidone solid SMEDDS and liquisolid compact. Drug Dev Ind Pharm [Internet]. 2020 Apr 2 [cited 2023 Jun 5];46(4):587–96. Available from:

Alalaiwe A, Alsenaidy MA, Almalki ZS. Development and Optimization of Sildenafil Orodispersible Mini-Tablets (ODMTs) for Treatment of Pediatric Pulmonary Hypertension Using Response Surface Methodology. 2023;15:923.